Health Care • Medical/Dental Instruments
$2.97 ▲ +0.04
(+1.37%)
MKT CAP: $126.7M • VOL: 1.22M
52W L $1 52W H $5
SKYA // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $204.1K | $0 | $0 |
| YoY Revenue Growth % | — | — | — |
| Gross Profit | -$413.3K | — | — |
| Gross Margin % | -50.0% | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$269.7M | -$5.6M | -$10.1M |
| Operating Margin % | -80.0% | — | — |
| Net Income (GAAP) | -$282.5M | -$9.3M | -$9.8M |
| EBITDA (Normalized) | — | -$5.5M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$11.0M | -$4.4M | -$8.5M |
| Capital Expenditures (CapEx) | — | $138.8K | — |
| Free Cash Flow (FCF) | -$11.0M | -$4.5M | -$8.5M |
| FCF Margin % | -80.0% | — | — |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $10.4M | $754.8K | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $264.4M | $2.0M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR SKYA.